Initial experience with a new 8 french-compatible directional atherectomy catheter: Immediate and mid-term results

Catheterization and Cardiovascular Interventions

Volumn 60, Issue 2, 2003, Pages 159-166

  Orlic, Dejan ^a   Reimers, Bernhard ^b   Stankovic, Goran ^a   Corvaja, Nicola ^a   Chieffo, Alaide ^c   Airoldi, Flavio ^c   Spanos, Vassilis ^a   Favero, Luca ^b   Di Mario, Carlo ^a   Colombo, Antonio ^a,c,d  

^a EMO GVM Centro Cuore   (Italy)

^b Mirano Hospital   (Italy)

^c SAN RAFFAELE HOSPITAL   (Italy)

^d EMO GVM CENTRO CUORE COLUMBUS   (Italy)

Author keywords

Atherectomy; Complex lesions; Stenting

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; TICLOPIDINE;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTERY CATHETER; ARTERY OCCLUSION; ARTICLE; ATHERECTOMY; ATHEROSCLEROTIC PLAQUE; BALLOON CATHETER; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY STENT; DEVICE; FEMALE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; REVASCULARIZATION;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ATHERECTOMY, CORONARY; BLOOD VESSEL PROSTHESIS; CALCINOSIS; CATHETERS, INDWELLING; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; EQUIPMENT DESIGN; EQUIPMENT SAFETY; FEMALE; FIBRINOLYTIC AGENTS; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; STENTS; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 10744226616     PISSN: 15221946     EISSN: None     Source Type: Journal    
DOI: 10.1002/ccd.10633     Document Type: Article

References (12)

1. Takagi T, Di Mario C, Stankovic G, et al. Effective plaque removal with a new 8 French-compatible atherectomy catheter. Cathet Cardiovasc Intervent 2002;56:452-459.
2. Baim DS, Cutlip DE, Sharma SK, et al. Final results of the Balloon vs. Optimal Atherectomy Trial (BOAT). Circulation 1998;97:322-331.
3. Simonton CA, Leon MB, Baim DS, et al. "Optimal" directional coronary atherectomy: final results of the Optimal Atherectomy Restenosis Study (OARS). Circulation 1998;97:332-339.
4. Hopp HW, Baer FM, Ozbek C, Kuck KH, Scheller B. A synergistic approach to optimal stenting: directional coronary atherectomy prior to coronary artery stent implantation-the AtheroLink Registry. J Am Coll Cardiol 2000;36:1853-1859.
5. Moussa I, Moses J, Di Mario C, et al. Stenting after optimal lesion debulking (sold) registry: angiographic and clinical outcome. Circulation 1998;98:1604-1609.
6. Colombo A, on behalf of the AMIGO investigators. Atherectomy before Multi-Link improves luminal gain and clinical outcomes (AMIGO): a comparison of coronary stenting with or without adjunctive directional atherectomy. J Am Coll Cardiol 2002;40:1-18.
7. Harrington RA, Lincoff AM, Califf RM, et al. Characteristics and consequences of myocardial infarction after percutaneous coronary intervention: insights from the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT). J Am Coll Cardiol 1995;25:1693-1699.
8. Topol EJ, Leya F, Pinkerton CA, et al. A comparison of directional atherectomy with coronary angioplasty in patients with coronary artery disease: the CAVEAT study group. N Engl J Med 1993;329:221-227.
9. Lefkovits J, Blankenship JC, Anderson KM, et al. Increased risk of non-Q wave myocardial infarction after directional atherectomy is platelet dependent: evidence from the EPIC trial. J Am Coll Cardiol 1996;28:849-855.
10. Moliterno DJ, Califf RM, Aguirre FV, et al. Effect of platelet glycoprotein IIb/IIIa integrin blockade on activated clotting time during percutaneous transluminal coronary angioplasty or directional atherectomy (the EPIC trial): evaluation of c7E3 Fab in the prevention of ischemic complications trial. Am J Cardiol 1995; 75:559-562.
11. Topol EJ, Yadav JS. Recognition of the importance of embolization in atherosclerotic vascular disease. Circulation 2000;101: 570-580.
12. Bramucci E, Angoli L, Merlini PA, et al. Adjunctive stent implantation following directional coronary atherectomy in patients with coronary artery disease. J Am Coll Cardiol 1998;32:1855-1860.